[Common name] Premixed Protamine Recombinant Human Insulin Injection (50/50)

[Ingredients] This product is composed of 50% recombinant human insulin injection and 50% protamine recombinant human insulin injection.

[Active ingredients] Recombinant human insulin (With the application of gene recombination technology, express the production with saccharomycetes). 1IU (international unit) is equivalent to 0.035mg anhydrous human insulin.

[Indication] It is indicated for diabetes.

[Specification] 3ml：300 international units (10.5mg), (pen core)

[Usage and Dosage] This product is a kind of dual phase insulin preparation. Its dual phase composition includes short-acting insulin and intermediate-acting insulin. When fast-acting and prolonged effectiveness is required, mixed insulin may be generally rendered once or twice a day. For subcutaneous injection, the dosage shall be decided by the doctor depending on the condition of disease.

[Package] Pen core is made of type 1 glass, including brombutyl rubber piston and brombutyl/polyisoprene rubber membrane. The glass bean inside pen core facilitates repetitive mixing of insulin. 1 pcs/bottle

[Expiry Date] 24 months

[Executive Standard] State Food and Drug Administration, Standard YBS00552010

[Approval Document Number] G (J) S20100014